-- With the global brain health market projected to grow from US$8.6 billion in 2024 to over US$15 billion by 2030 at a CAGR of ~9%, and the annual cost of dementia in the U.S. expected to reach US$781 billion by 2025, Tahiro is accelerating its U.S. expansion. Supported by its ongoing Regulation CF crowdfunding campaign, Tahiro is positioned at the forefront of one of the most pressing challenges of the time: protecting brain health and addressing the growing burden of cognitive decline.
United States — September 2025 — With the global brain health market projected to grow from $8.6 billion in 2024 to more than $15 billion by 2030, at a CAGR of nearly 9%, and the annual cost of dementia in the U.S. expected to reach $781 billion by 2025, Tahiro is scaling its U.S. operations to meet rising demand. Backed by its live Regulation CF crowdfunding campaign on DealMaker, Tahiro is positioned at the forefront of one of the most urgent challenges of the time: protecting cognitive health and reducing the burden of dementia worldwide.
Demographics Driving Demand
By 2030, one in five Americans will be over 65, fueling unprecedented demand for brain health solutions. Globally, someone is diagnosed with dementia every three seconds, underscoring the urgency for prevention and early intervention.
The economic impact is staggering, combining direct medical costs, long-term care expenses, and productivity losses. At the same time, consumer demand is rising, with growing awareness of memory, focus, and healthy aging driving double-digit growth in the cognitive wellness sector.
Tahiro’s Distinctive Edge
- Recurring revenue model: Tahiro’s subscriber community is expanding rapidly, ensuring predictable growth and long-term customer retention.
- Patented innovation: Proprietary delivery technologies, patent pending, provides a durable scientific and competitive advantage.
- Accessibility advantage: Tahiro products are eligible under Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA), making brain health support more affordable for millions of U.S. consumers.
World-Class Scientific Leadership
- Prof. Oded Shoseyov, Co-Founder & Chief Scientist — globally recognized expert in protein engineering and nanobiotechnology, with nearly 100 patents and more than 300 scientific publications.
- Ronit Shaltiel-Karyo, Ph.D., R&D and Innovation Consultant — biotech leader with a track record of transforming advanced research into scalable consumer-ready health solutions.
Looking Ahead
Tahiro’s roadmap includes expanding its U.S. subscriber base, securing additional IP, and building partnerships with leading health and wellness networks to broaden distribution. With its crowdfunding campaign now open on DealMaker, Tahiro is inviting investors to help make proactive brain health solutions more accessible worldwide.
“As life expectancy rises, cognitive decline is becoming one of the greatest challenges of our time,” said Prof. Oded Shoseyov, Co-Founder & Chief Scientist of Tahiro. “At Tahiro, our mission is to empower millions to age healthier by combining world-class science, patented innovation, and accessible consumer models. We believe that by bringing more partners and investors into this mission, we can scale faster and make a greater impact.”
About Tahiro
Tahiro is a U.S.-based brain health company dedicated to advancing innovation in cognitive wellness and healthier aging. With patented technologies, an expanding subscriber base, and leadership from Prof. Oded Shoseyov and Ronit Shaltiel-Karyo, Ph.D., Tahiro is committed to supporting lifelong brain health and reducing the societal costs associated with cognitive decline.
To learn more or participate in Tahiro’s crowdfunding campaign, visit invest.tahiro.com .
In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. Tahiro has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here.
Contact Info:
Name: Tahiro
Email: Send Email
Organization: Tahiro
Address: 3435 Ocean Park Blvd, Ste 107/803 Santa Monica, CA 90405, USA
Phone: 1-844-4-824476
Website: https://tahiro.com/
Release ID: 89171384
In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
